Clinical Trial Update: Creating an Innovative AI-based Technology TCRact for Designing and Optimizing T-cell Receptors (TCR) for Use in Cancer Immunotherapies

View source ↗

Summary

A completed clinical trial update on Ardigen's AI-based TCRact technology for designing and optimizing T-cell receptors for cancer immunotherapies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Colon Cancer

Snippet

Sponsor: Ardigen | Conditions: Colon Cancer, Cancer | Status: COMPLETED